MKS Instruments (MKSI) Financials

$74.47 -1.36 (-1.79%)

Closing price 04:00 PM Eastern

Extended Trading

$74.31 -0.16 (-0.21%)

As of 07:56 PM Eastern

Annual Income Statements for MKS Instruments

This table shows MKS Instruments' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Net Income / (Loss) Attributable to Common Shareholders	122	105	339	393	140	350	551	333	-1,841	190
Consolidated Net Income / (Loss)	122	105	339	393	140	350	551	333	-1,841	190
Net Income / (Loss) Continuing Operations	122	105	339	393	140	350	551	333	-1,841	190
Total Pre-Tax Income	159	128	448	481	178	423	665	433	-1,928	180
Total Operating Income	157	157	407	494	220	454	699	617	-1,554	498
Total Gross Profit	363	1,295	891	980	830	1,049	1,380	1,547	1,642	1,708
Total Revenue	814	1,295	1,916	2,075	1,900	2,330	2,950	3,547	3,622	3,586
Operating Revenue	814	1,295	1,916	2,075	1,900	2,330	2,950	3,547	3,622	3,586
Total Cost of Revenue	451	0.00	1,025	1,096	1,069	1,281	1,570	2,000	1,980	1,878
Operating Cost of Revenue	451	-	1,025	1,096	1,069	1,281	1,570	2,000	1,980	1,878
Total Operating Expenses	206	1,138	485	485	611	595	681	930	3,196	1,210
Selling, General & Admin Expense	129	228	290	298	330	353	385	488	675	674
Research & Development Expense	68	111	133	136	164	173	200	241	288	271
Amortization Expense	6.76	36	46	44	67	55	55	146	295	245
Other Operating Expenses / (Income)	-	731	0.49	0.40	6.60	-	0.00	0.00	2.00	5.00
Impairment Charge	-	5.00	6.72	0.00	4.70	-	0.00	0.00	1,902	0.00
Restructuring Charge	2.10	28	9.25	7.70	44	14	41	62	36	15
Other Special Charges / (Income)	-	-	-	0.00	-6.80	0.00	0.00	-7.00	-2.00	0.00
Total Other Income / (Expense), net	2.86	-29	41	-13	-42	-31	-34	-184	-374	-318
Interest Expense	0.14	31	31	17	44	29	25	177	364	341
Interest & Investment Income	3.00	2.56	3.02	5.80	5.40	1.00	0.00	4.00	17	21
Other Income / (Expense), net	-	-1.24	69	-2.00	-3.30	-3.00	-9.00	-11	-27	2.00
Income Tax Expense	37	23	108	88	37	73	114	100	-87	-10
Basic Earnings per Share	$2.30	$1.96	$6.26	$7.22	$2.57	$6.36	$9.95	$5.57	($27.54)	$2.82
Weighted Average Basic Shares Outstanding	53.28M	53.47M	54.14M	54.41M	54.70M	55.10M	55.40M	59.70M	66.80M	67.30M
Diluted Earnings per Share	$2.28	$1.94	$6.16	$7.14	$2.55	$6.33	$9.90	$5.56	($27.54)	$2.81
Weighted Average Diluted Shares Outstanding	53.56M	54.05M	55.07M	55M	55.10M	55.30M	55.70M	59.90M	66.80M	67.60M
Weighted Average Basic & Diluted Shares Outstanding	53.20M	53.50M	54.20M	54.40M	54.87M	55.22M	55.52M	66.67M	67.06M	67.38M
Cash Dividends to Common per Share	$0.68	$0.68	$0.71	$0.78	$0.80	$0.80	$0.86	$0.88	$0.88	$0.88

This table shows MKS Instruments' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024
Net Income / (Loss) Attributable to Common Shareholders	6.00	54	-42	-1,769	39	-69	15	23	62	90
Consolidated Net Income / (Loss)	6.00	54	-42	-1,769	39	-69	15	23	62	90
Net Income / (Loss) Continuing Operations	6.00	54	-42	-1,769	39	-69	15	23	62	90
Total Pre-Tax Income	40	66	-79	-1,791	22	-80	19	22	60	79
Total Operating Income	118	163	1.00	-1,696	118	23	106	127	128	137
Total Gross Profit	390	485	335	470	426	411	415	419	432	442
Total Revenue	954	1,086	794	1,003	932	893	868	887	896	935
Operating Revenue	954	1,086	794	1,003	932	893	868	887	896	935
Total Cost of Revenue	564	601	459	533	506	482	453	468	464	493
Operating Cost of Revenue	564	601	459	533	506	482	453	468	464	493
Total Operating Expenses	272	322	334	2,166	308	388	309	292	304	305
Selling, General & Admin Expense	126	169	174	172	167	162	170	161	167	176
Research & Development Expense	63	73	72	75	71	70	70	66	70	65
Amortization Expense	47	69	81	76	68	70	62	61	61	61
Restructuring Charge	36	11	7.00	16	4.00	9.00	4.00	4.00	4.00	3.00
Total Other Income / (Expense), net	-78	-97	-80	-95	-96	-103	-87	-105	-68	-58
Interest Expense	80	84	85	88	93	98	96	117	69	59
Interest & Investment Income	1.00	2.00	3.00	4.00	4.00	6.00	6.00	5.00	6.00	4.00
Other Income / (Expense), net	1.00	-15	2.00	-11	-7.00	-11	3.00	7.00	-5.00	-3.00
Income Tax Expense	34	12	-37	-22	-17	-11	4.00	-1.00	-2.00	-11
Basic Earnings per Share	$0.09	$0.57	($0.64)	($26.47)	$0.59	($1.02)	$0.22	$0.34	$0.92	$1.34
Weighted Average Basic Shares Outstanding	61M	59.70M	66.70M	66.80M	66.90M	66.80M	67M	67.30M	67.40M	67.30M
Diluted Earnings per Share	$0.09	$0.58	($0.64)	($26.47)	$0.58	($1.01)	$0.22	$0.33	$0.92	$1.34
Weighted Average Diluted Shares Outstanding	61.10M	59.90M	66.70M	66.80M	67.10M	66.80M	67.40M	67.50M	67.60M	67.60M
Weighted Average Basic & Diluted Shares Outstanding	66.51M	66.67M	66.77M	66.86M	66.88M	67.06M	67.20M	67.29M	67.30M	67.38M

This table details how cash moves in and out of MKS Instruments' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Net Change in Cash & Equivalents	-78	6.34	100	309	-230	193	358	-57	-34	-161
Net Cash From Operating Activities	138	180	355	414	245	513	640	529	319	528
Net Cash From Continuing Operating Activities	138	180	355	414	245	513	640	529	319	528
Net Income / (Loss) Continuing Operations	122	105	339	393	140	350	551	333	-1,841	190
Consolidated Net Income / (Loss)	122	105	339	393	140	350	551	333	-1,841	190
Depreciation Expense	22	66	83	80	110	99	104	216	397	348
Amortization Expense	-	24	11	4.70	15	3.00	2.00	108	33	30
Non-Cash Adjustments To Reconcile Net Income	26	46	11	54	72	58	57	62	2,031	169
Changes in Operating Assets and Liabilities, net	-32	-61	-88	-117	-93	3.00	-74	-190	-301	-209
Net Cash From Investing Activities	-167	-727	23	73	-947	-202	-205	-4,552	-84	-117
Net Cash From Continuing Investing Activities	-167	-727	23	73	-947	-202	-205	-4,552	-84	-117
Purchase of Property, Plant & Equipment	-12	-19	-31	-63	-64	-85	-87	-164	-87	-118
Acquisitions	-9.91	-940	-	0.00	-989	0.00	-268	-4,473	0.00	0.00
Purchase of Investments	-386	-268	-230	-254	-246	-522	-497	-1.00	0.00	0.00
Sale of Property, Plant & Equipment	-	-	-	0.00	42	0.00	0.00	9.00	3.00	1.00
Sale and/or Maturity of Investments	241	500	211	389	310	405	647	77	0.00	0.00
Net Cash From Financing Activities	-47	560	-280	-178	476	-122	-65	3,971	-259	-549
Net Cash From Continuing Financing Activities	-47	560	-280	-178	476	-122	-65	3,971	-259	-549
Repayment of Debt	-	-165	-258	-117	-112	-84	-15	-1,213	-415	-2,642
Payment of Dividends	-36	-36	-38	-42	-44	-44	-47	-52	-59	-59
Issuance of Debt	-	764	29	68	642	27	1.00	5,237	216	2,161
Other Financing Activities, net	2.17	-0.45	-12	-11	-11	-21	-4.00	-1.00	-1.00	-9.00
Effect of Exchange Rate Changes	-1.69	-	-	-	-	4.00	-12	-5.00	-	-23
Cash Interest Paid	0.03	21	20	15	40	26	23	110	305	268
Cash Income Taxes Paid	43	45	105	92	36	66	110	133	180	145

This table details how cash moves in and out of MKS Instruments' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024
Net Change in Cash & Equivalents	-181	25	-29	-123	102	16	-30	5.00	11	-147
Net Cash From Operating Activities	199	184	37	-59	160	181	67	122	163	176
Net Cash From Continuing Operating Activities	199	184	37	-59	160	181	67	122	163	176
Net Income / (Loss) Continuing Operations	6.00	54	-42	-1,770	40	-69	15	22	62	91
Consolidated Net Income / (Loss)	6.00	54	-42	-1,770	40	-69	15	22	62	91
Depreciation Expense	64	96	107	101	93	96	88	87	87	86
Amortization Expense	85	23	8.00	7.00	8.00	10	8.00	8.00	7.00	7.00
Non-Cash Adjustments To Reconcile Net Income	26	62	2.00	1,852	61	116	7.00	47	55	60
Changes in Operating Assets and Liabilities, net	18	-51	-38	-249	-42	28	-51	-42	-48	-68
Net Cash From Investing Activities	-4,499	-52	-17	-17	-16	-34	-18	-26	-22	-51
Net Cash From Continuing Investing Activities	-4,499	-52	-17	-17	-16	-34	-18	-26	-22	-51
Purchase of Property, Plant & Equipment	-26	-55	-17	-18	-18	-34	-18	-27	-22	-51
Net Cash From Financing Activities	4,139	-137	-43	-35	-38	-143	-72	-87	-144	-246
Net Cash From Continuing Financing Activities	4,139	-137	-43	-35	-38	-143	-72	-87	-144	-246
Repayment of Debt	-827	-378	-24	-21	-23	-347	-809	-1,470	-129	-234
Payment of Dividends	-13	-15	-15	-14	-15	-15	-15	-15	-14	-15
Other Financing Activities, net	-	4.00	-6.00	1.00	-	4.00	-9.00	-2.00	-1.00	3.00
Effect of Exchange Rate Changes	-20	30	-6.00	-12	-4.00	-	-7.00	-4.00	14	-26

This table presents MKS Instruments' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Total Assets	1,273	2,212	2,414	2,614	3,416	3,904	4,540	11,495	9,118	8,590
Total Current Assets	940	999	1,236	1,464	1,434	1,804	2,147	2,794	2,696	2,474
Cash & Equivalents	228	229	334	644	415	608	966	909	875	714
Accounts Receivable	102	249	300	295	341	393	443	720	603	615
Inventories, net	153	276	339	385	462	501	577	977	991	893
Other Current Assets	18	51	54	66	106	74	85	187	227	252
Plant, Property, & Equipment, net	69	175	172	194	242	284	326	800	784	771
Total Noncurrent Assets	265	1,039	1,006	956	1,741	1,815	2,067	7,901	5,638	5,345
Goodwill	200	589	591	587	1,059	1,066	1,228	4,308	2,554	2,479
Intangible Assets	44	408	366	320	565	512	576	3,173	2,619	2,272
Other Noncurrent Operating Assets	21	32	38	39	112	230	263	420	465	594
Total Liabilities & Shareholders' Equity	1,273	2,212	2,414	2,614	3,416	3,904	4,540	11,495	9,118	8,590
Total Liabilities	112	970	825	741	1,393	1,543	1,653	7,012	6,646	6,268
Total Current Liabilities	91	237	290	263	318	374	460	952	848	775
Short-Term Debt	-	11	2.97	3.99	12	15	9.00	93	93	50
Accounts Payable	23	69	83	84	88	111	168	426	327	341
Other Current Liabilities	28	52	61	63	79	81	89	433	428	384
Total Noncurrent Liabilities	21	733	535	478	1,075	1,169	1,193	6,060	5,798	5,493
Long-Term Debt	-	601	390	344	872	815	808	4,834	4,696	4,488
Noncurrent Deferred & Payable Income Tax Liabilities	2.66	66	62	48	72	59	99	783	640	504
Noncurrent Employee Benefit Liabilities	13	45	52	56	44	50	49	138	151	141
Other Noncurrent Operating Liabilities	5.43	21	32	30	87	245	237	305	311	360
Commitments & Contingencies	0.00	0.00	0.00	0.00	-	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	1,161	1,242	1,589	1,873	2,023	2,361	2,887	4,483	2,472	2,322
Total Preferred & Common Equity	1,161	1,242	1,589	1,873	2,023	2,361	2,887	4,483	2,472	2,322
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	1,161	1,242	1,589	1,873	2,023	2,361	2,887	4,483	2,472	2,322
Common Stock	745	778	790	794	864	873	907	2,142	2,195	2,067
Retained Earnings	427	495	796	1,085	1,181	1,487	1,991	2,272	373	503
Accumulated Other Comprehensive Income / (Loss)	-11	-31	3.45	-5.66	-22	0.30	-11	69	-96	-248

This table presents MKS Instruments' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024
Period end date	9/30/2022	3/31/2023	6/30/2023	9/30/2023	3/31/2024	6/30/2024	9/30/2024
Total Assets	11,372	11,366	9,230	9,140	8,931	8,863	9,023
Total Current Assets	2,791	2,748	2,728	2,775	2,661	2,648	2,668
Cash & Equivalents	884	880	757	859	845	850	861
Accounts Receivable	730	572	631	618	576	597	609
Inventories, net	961	1,058	1,036	1,009	971	938	940
Other Current Assets	215	237	303	288	268	262	258
Plant, Property, & Equipment, net	655	794	777	761	766	759	770
Total Noncurrent Assets	7,926	7,824	5,725	5,604	5,504	5,456	5,585
Goodwill	3,851	4,327	2,575	2,540	2,511	2,495	2,567
Intangible Assets	3,653	3,108	2,728	2,614	2,501	2,418	2,443
Other Noncurrent Operating Assets	422	389	422	450	492	543	575
Total Liabilities & Shareholders' Equity	11,372	11,366	9,230	9,140	8,931	8,863	9,023
Total Liabilities	7,223	6,915	6,735	6,664	6,507	6,630	6,625
Total Current Liabilities	1,011	876	835	838	721	740	781
Short-Term Debt	95	88	88	87	50	50	50
Accounts Payable	410	372	314	309	290	291	306
Other Current Liabilities	219	416	433	442	381	399	425
Total Noncurrent Liabilities	6,212	6,039	5,900	5,826	5,786	5,890	5,844
Long-Term Debt	4,893	4,837	4,819	4,787	4,692	4,832	4,758
Noncurrent Deferred & Payable Income Tax Liabilities	893	751	628	595	622	588	590
Noncurrent Employee Benefit Liabilities	131	138	143	139	148	144	154
Other Noncurrent Operating Liabilities	295	313	310	305	324	326	342
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	4,149	4,451	2,495	2,476	2,424	2,233	2,398
Total Preferred & Common Equity	4,149	4,451	2,495	2,476	2,424	2,233	2,398
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	4,149	4,451	2,495	2,476	2,424	2,233	2,398
Common Stock	2,124	2,154	2,168	2,180	2,201	2,042	2,053
Retained Earnings	2,233	2,215	431	455	373	381	428
Accumulated Other Comprehensive Income / (Loss)	-208	82	-104	-159	-150	-190	-83

This table displays calculated financial ratios and metrics derived from MKS Instruments' official financial filings.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	4.18%	59.23%	47.91%	8.31%	-8.45%	22.64%	26.61%	20.24%	2.11%	-0.99%
EBITDA Growth	13.23%	37.82%	130.95%	1.36%	-40.83%	62.08%	43.94%	16.83%	-223.76%	176.28%
EBIT Growth	15.89%	-0.37%	204.81%	3.47%	-56.00%	108.31%	52.99%	-12.17%	-360.89%	131.63%
NOPAT Growth	4.70%	7.24%	139.20%	31.01%	-57.00%	116.43%	54.18%	-18.07%	-329.25%	148.32%
Net Income Growth	5.63%	-14.30%	223.57%	15.85%	-64.27%	149.29%	57.43%	-39.56%	-652.85%	110.32%
EPS Growth	5.56%	-14.91%	217.53%	15.91%	-64.29%	148.24%	56.40%	-43.84%	-595.32%	110.20%
Operating Cash Flow Growth	35.70%	30.23%	97.24%	16.49%	-40.91%	109.82%	24.76%	-17.34%	-39.70%	65.52%
Free Cash Flow Firm Growth	3,273.89%	-837.34%	138.13%	12.62%	-309.82%	156.95%	-34.56%	-2,123.41%	119.13%	-25.39%
Invested Capital Growth	2.67%	182.66%	0.50%	4.53%	59.28%	-1.24%	13.38%	219.31%	-24.87%	-3.76%
Revenue Q/Q Growth	-3.63%	21.90%	5.90%	-2.41%	-18.63%	37.44%	3.65%	9.98%	-5.06%	1.19%
EBITDA Q/Q Growth	-8.50%	48.19%	11.41%	-4.64%	-5.67%	16.27%	5.71%	6.04%	-14.87%	14.17%
EBIT Q/Q Growth	-9.45%	33.41%	14.14%	-4.75%	-12.31%	22.89%	6.01%	-5.90%	-9.41%	32.28%
NOPAT Q/Q Growth	-7.02%	31.70%	11.01%	-2.56%	-11.56%	22.61%	6.02%	-5.27%	-9.90%	-7.27%
Net Income Q/Q Growth	-6.62%	23.53%	10.47%	-1.50%	-17.04%	26.22%	6.89%	-22.56%	-7.16%	512.90%
EPS Q/Q Growth	-6.56%	23.57%	10.20%	-1.24%	-17.74%	26.35%	6.45%	-27.51%	-6.13%	510.87%
Operating Cash Flow Q/Q Growth	6.56%	5.88%	8.58%	15.23%	-19.25%	15.75%	8.11%	-2.04%	-0.93%	-0.94%
Free Cash Flow Firm Q/Q Growth	3.23%	2.96%	0.20%	18.12%	-9.63%	16.70%	21.27%	-5.38%	32.89%	7.56%
Invested Capital Q/Q Growth	-2.17%	-0.29%	1.84%	-2.41%	0.13%	0.61%	0.03%	3.01%	-1.60%	-3.14%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	44.61%	100.00%	46.53%	47.20%	43.71%	45.02%	46.78%	43.61%	45.33%	47.63%
EBITDA Margin	21.97%	19.02%	29.69%	27.79%	17.96%	23.73%	26.98%	26.22%	-31.78%	24.48%
Operating Margin	19.25%	12.14%	21.22%	23.81%	11.57%	19.49%	23.69%	17.40%	-42.90%	13.89%
EBIT Margin	19.25%	12.05%	24.82%	23.71%	11.40%	19.36%	23.39%	17.08%	-43.65%	13.94%
Profit (Net Income) Margin	15.03%	8.09%	17.70%	18.93%	7.39%	15.02%	18.68%	9.39%	-50.83%	5.30%
Tax Burden Percent	76.69%	81.90%	75.76%	81.68%	78.97%	82.74%	82.86%	76.91%	95.49%	105.56%
Interest Burden Percent	101.82%	82.02%	94.12%	97.74%	82.12%	93.79%	96.38%	71.45%	121.95%	36.00%
Effective Tax Rate	23.31%	18.10%	24.24%	18.32%	21.03%	17.26%	17.14%	23.09%	0.00%	-5.56%
Return on Invested Capital (ROIC)	24.21%	13.39%	21.63%	27.64%	8.97%	15.90%	23.12%	8.50%	-14.62%	8.39%
ROIC Less NNEP Spread (ROIC-NNEP)	23.86%	23.40%	367.08%	31.59%	258.02%	0.86%	46.79%	1.04%	-33.61%	-0.29%
Return on Net Nonoperating Assets (RNNOA)	-13.30%	-4.67%	2.33%	-4.94%	-1.76%	0.07%	-2.12%	0.53%	-38.33%	-0.46%
Return on Equity (ROE)	10.91%	8.72%	23.96%	22.70%	7.21%	15.97%	21.00%	9.04%	-52.94%	7.93%
Cash Return on Invested Capital (CROIC)	21.58%	-82.08%	21.13%	23.21%	-36.75%	17.14%	10.58%	-96.10%	13.79%	12.22%
Operating Return on Assets (OROA)	12.54%	8.95%	20.56%	19.57%	7.18%	12.32%	16.34%	7.56%	-15.34%	5.65%
Return on Assets (ROA)	9.79%	6.01%	14.66%	15.63%	4.66%	9.56%	13.05%	4.15%	-17.86%	2.15%
Return on Common Equity (ROCE)	10.91%	8.72%	23.96%	22.70%	7.21%	15.97%	21.00%	9.04%	-52.94%	7.93%
Return on Equity Simple (ROE_SIMPLE)	10.53%	8.44%	21.34%	20.97%	6.94%	14.82%	19.09%	7.43%	-74.47%	8.18%
Net Operating Profit after Tax (NOPAT)	120	129	308	404	174	376	579	475	-1,088	526
NOPAT Margin	14.76%	9.94%	16.08%	19.45%	9.14%	16.12%	19.63%	13.38%	-30.03%	14.66%
Net Nonoperating Expense Percent (NNEP)	0.35%	-10.01%	-345.45%	-3.95%	-249.05%	15.04%	-23.67%	7.46%	18.99%	8.68%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	5.04%	-14.98%	7.66%
Cost of Revenue to Revenue	55.40%	0.00%	53.47%	52.80%	56.29%	54.98%	53.22%	56.39%	54.67%	52.37%
SG&A Expenses to Revenue	15.87%	17.60%	15.14%	14.37%	17.39%	15.15%	13.05%	13.76%	18.64%	18.80%
R&D to Revenue	8.40%	8.54%	6.92%	6.54%	8.64%	7.42%	6.78%	6.79%	7.95%	7.56%
Operating Expenses to Revenue	25.35%	87.86%	25.30%	23.39%	32.14%	25.54%	23.08%	26.22%	88.24%	33.74%
Earnings before Interest and Taxes (EBIT)	157	156	476	492	217	451	690	606	-1,581	500
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	179	246	569	577	341	553	796	930	-1,151	878
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	1.53	2.41	3.07	1.78	2.87	3.42	3.28	1.23	2.76	3.02
Price to Tangible Book Value (P/TBV)	1.94	12.23	7.72	3.46	14.49	10.33	8.73	0.00	0.00	0.00
Price to Revenue (P/Rev)	2.18	2.31	2.54	1.61	3.05	3.47	3.21	1.56	1.88	1.95
Price to Earnings (P/E)	14.53	28.61	14.37	8.50	41.31	23.08	17.16	16.60	0.00	36.90
Dividend Yield	2.02%	1.22%	0.79%	1.26%	0.75%	0.55%	0.50%	1.06%	0.86%	0.84%
Earnings Yield	6.88%	3.50%	6.96%	11.76%	2.42%	4.33%	5.83%	6.02%	0.00%	2.71%
Enterprise Value to Invested Capital (EV/IC)	2.23	2.24	3.30	1.98	2.59	3.43	3.47	1.12	1.68	1.76
Enterprise Value to Revenue (EV/Rev)	1.38	2.45	2.46	1.43	3.24	3.46	3.13	2.69	2.96	3.02
Enterprise Value to EBITDA (EV/EBITDA)	6.26	12.90	8.29	5.14	18.04	14.58	11.60	10.26	0.00	12.34
Enterprise Value to EBIT (EV/EBIT)	7.14	20.36	9.91	6.02	28.42	17.88	13.38	15.75	0.00	21.67
Enterprise Value to NOPAT (EV/NOPAT)	9.31	24.67	15.30	7.34	35.45	21.47	15.94	20.11	0.00	20.61
Enterprise Value to Operating Cash Flow (EV/OCF)	8.09	17.64	13.27	7.16	25.17	15.72	14.42	18.04	33.64	20.52
Enterprise Value to Free Cash Flow (EV/FCFF)	10.45	0.00	15.66	8.74	0.00	19.91	34.82	0.00	10.46	14.15
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.49	0.25	0.19	0.44	0.35	0.28	1.10	1.94	1.95
Long-Term Debt to Equity	0.00	0.48	0.25	0.18	0.43	0.35	0.28	1.08	1.90	1.93
Financial Leverage	-0.56	-0.20	0.01	-0.16	-0.01	0.08	-0.05	0.51	1.14	1.61
Leverage Ratio	1.11	1.45	1.63	1.45	1.55	1.67	1.61	2.18	2.96	3.69
Compound Leverage Factor	1.13	1.19	1.54	1.42	1.27	1.57	1.55	1.55	3.61	1.33
Debt to Total Capital	0.00%	33.02%	19.83%	15.66%	30.40%	26.00%	22.06%	52.36%	65.96%	66.15%
Short-Term Debt to Total Capital	0.00%	0.59%	0.15%	0.18%	0.42%	0.45%	0.24%	0.99%	1.28%	0.73%
Long-Term Debt to Total Capital	0.00%	32.43%	19.68%	15.48%	29.99%	25.55%	21.81%	51.37%	64.67%	65.42%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	100.00%	66.98%	80.17%	84.34%	69.60%	74.00%	77.94%	47.64%	34.04%	33.85%
Debt to EBITDA	0.00	2.49	0.69	0.60	2.59	1.50	1.03	5.30	-4.16	5.17
Net Debt to EBITDA	0.00	0.73	-0.28	-0.66	1.04	-0.02	-0.28	4.32	-3.40	4.36
Long-Term Debt to EBITDA	0.00	2.44	0.69	0.60	2.55	1.47	1.02	5.20	-4.08	5.11
Debt to NOPAT	0.00	4.75	1.28	0.86	5.09	2.21	1.41	10.38	-4.40	8.63
Net Debt to NOPAT	0.00	1.39	-0.52	-0.94	2.04	-0.03	-0.39	8.47	-3.60	7.27
Long-Term Debt to NOPAT	0.00	4.67	1.27	0.85	5.02	2.17	1.40	10.19	-4.32	8.54
Altman Z-Score	11.79	3.40	5.92	5.25	4.14	5.09	5.64	1.42	0.74	1.60
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	10.33	4.21	4.27	5.56	4.51	4.83	4.67	2.93	3.18	3.19
Quick Ratio	8.35	2.81	2.91	3.85	2.72	3.29	3.23	1.71	1.74	1.71
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	107	-789	301	339	-711	405	265	-5,363	1,026	766
Operating Cash Flow to CapEx	1,114.02%	941.79%	1,135.37%	657.87%	1,121.56%	603.53%	735.63%	341.29%	379.76%	451.28%
Free Cash Flow to Firm to Interest Expense	748.62	-25.79	9.71	20.06	-16.13	13.97	10.60	-30.30	2.82	2.25
Operating Cash Flow to Interest Expense	967.10	5.88	11.46	24.49	5.54	17.69	25.60	2.99	0.88	1.55
Operating Cash Flow Less CapEx to Interest Expense	880.29	5.26	10.45	20.76	5.05	14.76	22.12	2.11	0.65	1.21
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.65	0.74	0.83	0.83	0.63	0.64	0.70	0.44	0.35	0.41
Accounts Receivable Turnover	7.81	7.39	6.98	6.97	5.97	6.35	7.06	6.10	5.48	5.89
Inventory Turnover	2.93	0.00	3.33	3.03	2.53	2.66	2.91	2.57	2.01	1.99
Fixed Asset Turnover	11.49	10.64	11.06	11.33	8.71	8.86	9.67	6.30	4.57	4.61
Accounts Payable Turnover	15.72	0.00	13.49	13.17	12.42	12.87	11.27	6.73	5.26	5.62
Days Sales Outstanding (DSO)	46.72	49.40	52.30	52.40	61.15	57.48	51.70	59.84	66.66	61.99
Days Inventory Outstanding (DIO)	124.65	0.00	109.54	120.56	144.51	137.27	125.36	141.80	181.39	183.08
Days Payable Outstanding (DPO)	23.22	0.00	27.05	27.71	29.39	28.35	32.39	54.20	69.41	64.91
Cash Conversion Cycle (CCC)	148.14	49.40	134.79	145.25	176.27	166.39	144.67	147.44	178.65	180.16
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	503	1,421	1,428	1,493	2,377	2,348	2,662	8,500	6,386	6,146
Invested Capital Turnover	1.64	1.35	1.35	1.42	0.98	0.99	1.18	0.64	0.49	0.57
Increase / (Decrease) in Invested Capital	13	918	7.11	65	885	-29	314	5,838	-2,114	-240
Enterprise Value (EV)	1,119	3,177	4,713	2,961	6,154	8,065	9,231	9,545	10,730	10,834
Market Capitalization	1,777	2,998	4,874	3,342	5,800	8,078	9,456	5,528	6,816	7,010
Book Value per Share	$21.80	$23.17	$29.26	$34.70	$37.12	$42.82	$52.06	$67.41	$36.96	$34.50
Tangible Book Value per Share	$17.22	$4.58	$11.63	$17.90	$7.34	$14.19	$19.53	($45.08)	($40.39)	($36.09)
Total Capital	1,161	1,854	1,982	2,221	2,907	3,190	3,704	9,410	7,261	6,860
Total Debt	0.00	612	393	348	884	830	817	4,927	4,789	4,538
Total Long-Term Debt	0.00	601	390	344	872	815	808	4,834	4,696	4,488
Net Debt	-658	179	-161	-381	354	-13	-225	4,017	3,914	3,824
Capital Expenditures (CapEx)	12	19	31	63	22	85	87	155	84	117
Debt-free, Cash-free Net Working Capital (DFCFNWC)	190	349	406	487	604	609	654	1,025	1,066	1,035
Debt-free Net Working Capital (DFNWC)	849	772	949	1,205	1,128	1,445	1,696	1,935	1,941	1,749
Net Working Capital (NWC)	849	761	946	1,201	1,116	1,431	1,687	1,842	1,848	1,699
Net Nonoperating Expense (NNE)	-2.19	24	-31	11	33	26	28	142	753	336
Net Nonoperating Obligations (NNO)	-658	179	-161	-381	354	-13	-225	4,017	3,914	3,824
Total Depreciation and Amortization (D&A)	22	90	93	85	125	102	106	324	430	378
Debt-free, Cash-free Net Working Capital to Revenue	23.39%	26.95%	21.19%	23.45%	31.79%	26.14%	22.17%	28.90%	29.43%	28.86%
Debt-free Net Working Capital to Revenue	104.30%	59.63%	49.55%	58.06%	59.37%	62.02%	57.49%	54.55%	53.59%	48.77%
Net Working Capital to Revenue	104.30%	58.79%	49.40%	57.87%	58.73%	61.39%	57.19%	51.93%	51.02%	47.38%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$2.30	$1.96	$6.26	$7.22	$2.57	$6.36	$9.95	$5.57	($27.54)	$2.82
Adjusted Weighted Average Basic Shares Outstanding	53.28M	53.47M	54.14M	54.41M	54.71M	55.10M	55.40M	59.70M	66.80M	67.30M
Adjusted Diluted Earnings per Share	$2.28	$1.94	$6.16	$7.14	$2.55	$6.33	$9.90	$5.56	($27.54)	$2.81
Adjusted Weighted Average Diluted Shares Outstanding	53.56M	54.05M	55.07M	54.99M	55.11M	55.30M	55.70M	59.90M	66.80M	67.60M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	53.24M	53.82M	54.49M	54.20M	54.87M	55.22M	55.52M	66.67M	67.06M	67.38M
Normalized Net Operating Profit after Tax (NOPAT)	122	156	320	410	207	387	613	517	267	359
Normalized NOPAT Margin	14.96%	12.02%	16.71%	19.75%	10.89%	16.62%	20.78%	14.57%	7.38%	10.01%
Pre Tax Income Margin	19.60%	9.88%	23.36%	23.18%	9.36%	18.15%	22.54%	12.21%	-53.23%	5.02%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	1,095.19	5.10	15.35	29.12	4.91	15.55	27.60	3.42	-4.34	1.47
NOPAT to Interest Expense	839.91	4.21	9.94	23.88	3.94	12.95	23.17	2.68	-2.99	1.54
EBIT Less CapEx to Interest Expense	1,008.38	4.47	14.34	25.40	4.42	12.62	24.12	2.55	-4.57	1.12
NOPAT Less CapEx to Interest Expense	753.10	3.58	8.93	20.16	3.44	10.02	19.69	1.81	-3.22	1.20
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	29.41%	34.69%	11.26%	10.79%	30.98%	12.57%	8.53%	15.62%	-3.20%	31.05%
Augmented Payout Ratio	40.28%	36.17%	11.26%	29.88%	30.98%	12.57%	8.53%	15.62%	-3.20%	31.05%

This table displays calculated financial ratios and metrics derived from MKS Instruments' official financial filings.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	28.57%	42.15%	7.01%	31.11%	-2.31%	-17.77%	9.32%	-11.57%	-3.86%	4.70%
EBITDA Growth	34.67%	24.77%	-42.44%	-941.58%	-20.90%	-55.81%	73.73%	114.32%	2.36%	92.37%
EBIT Growth	-30.81%	-20.43%	-98.31%	-1,153.70%	-6.72%	-91.89%	3,533.33%	107.85%	10.81%	1,016.67%
NOPAT Growth	-87.28%	-13.14%	-99.51%	-968.68%	1,081.82%	-87.93%	11,854.89%	111.18%	-36.77%	869.42%
Net Income Growth	-95.45%	-64.24%	-129.37%	-1,460.77%	550.00%	-227.78%	135.71%	101.30%	58.97%	230.43%
EPS Growth	-96.22%	-78.44%	-124.90%	-1,240.95%	544.44%	-274.14%	134.38%	101.25%	58.62%	232.67%
Operating Cash Flow Growth	30.07%	-5.64%	-9.76%	-156.19%	-19.60%	-1.63%	81.08%	306.78%	1.88%	-2.76%
Free Cash Flow Firm Growth	-2,855.82%	-3,452.76%	-1,992.10%	-1,312.93%	135.37%	137.34%	139.61%	110.35%	-85.93%	-81.41%
Invested Capital Growth	210.07%	219.31%	204.26%	130.94%	-21.35%	-24.87%	-25.60%	-5.72%	-2.23%	-3.76%
Revenue Q/Q Growth	24.71%	13.84%	-26.89%	26.32%	-7.08%	-4.18%	-2.80%	2.19%	1.01%	4.35%
EBITDA Q/Q Growth	41.05%	-0.37%	-55.81%	-1,455.08%	113.26%	-44.34%	73.73%	11.71%	-5.24%	4.61%
EBIT Q/Q Growth	-26.54%	24.37%	-97.97%	-57,000.00%	106.50%	-89.19%	808.33%	22.94%	-8.21%	8.94%
NOPAT Q/Q Growth	-87.05%	653.47%	-99.48%	-169,700.00%	117.62%	-92.30%	419.78%	58.66%	-0.38%	18.00%
Net Income Q/Q Growth	-95.38%	800.00%	-177.78%	-4,111.90%	102.20%	-276.92%	121.74%	53.33%	169.57%	45.16%
EPS Q/Q Growth	-96.12%	544.44%	-210.34%	-4,035.94%	102.19%	-274.14%	121.78%	50.00%	178.79%	45.65%
Operating Cash Flow Q/Q Growth	89.52%	-7.54%	-79.89%	-259.46%	371.19%	13.13%	-62.98%	82.09%	33.61%	7.98%
Free Cash Flow Firm Q/Q Growth	-1,489.41%	-2.36%	0.04%	13.12%	139.79%	8.06%	6.04%	-77.30%	-45.93%	42.85%
Invested Capital Q/Q Growth	186.83%	3.01%	-0.06%	-21.79%	-2.32%	-1.60%	-1.03%	-0.89%	1.29%	-3.14%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	40.88%	44.66%	42.19%	46.86%	45.71%	46.02%	47.81%	47.24%	48.21%	47.27%
EBITDA Margin	28.09%	24.59%	14.86%	-159.42%	22.75%	13.21%	23.62%	25.82%	24.22%	24.28%
Operating Margin	12.37%	15.01%	0.13%	-169.09%	12.66%	2.58%	12.21%	14.32%	14.29%	14.65%
EBIT Margin	12.47%	13.63%	0.38%	-170.19%	11.91%	1.34%	12.56%	15.11%	13.73%	14.33%
Profit (Net Income) Margin	0.63%	4.97%	-5.29%	-176.37%	4.18%	-7.73%	1.73%	2.59%	6.92%	9.63%
Tax Burden Percent	15.00%	81.82%	53.16%	98.77%	177.27%	86.25%	78.95%	104.55%	103.33%	113.92%
Interest Burden Percent	33.61%	44.59%	-2,633.33%	104.92%	19.82%	-666.67%	17.43%	16.42%	48.78%	58.96%
Effective Tax Rate	85.00%	18.18%	0.00%	0.00%	-77.27%	0.00%	21.05%	-4.55%	-3.33%	-13.92%
Return on Invested Capital (ROIC)	1.10%	7.80%	0.06%	-95.40%	11.62%	0.88%	4.81%	8.30%	8.15%	9.55%
ROIC Less NNEP Spread (ROIC-NNEP)	0.51%	3.62%	-2.19%	-125.26%	7.42%	-1.27%	3.08%	5.62%	6.39%	7.85%
Return on Net Nonoperating Assets (RNNOA)	0.30%	1.86%	-1.11%	-86.80%	9.10%	-1.45%	3.56%	9.72%	10.43%	12.66%
Return on Equity (ROE)	1.39%	9.67%	-1.06%	-182.20%	20.71%	-0.57%	8.37%	18.02%	18.58%	22.22%
Cash Return on Invested Capital (CROIC)	-93.28%	-96.10%	-94.66%	-99.92%	10.48%	13.79%	15.67%	9.94%	11.09%	12.22%
Operating Return on Assets (OROA)	5.11%	6.03%	0.17%	-93.43%	4.43%	0.47%	4.57%	5.98%	5.36%	5.80%
Return on Assets (ROA)	0.26%	2.20%	-2.38%	-96.82%	1.56%	-2.72%	0.63%	1.03%	2.70%	3.90%
Return on Common Equity (ROCE)	1.39%	9.67%	-1.06%	-182.20%	20.71%	-0.57%	8.37%	18.02%	18.58%	22.22%
Return on Equity Simple (ROE_SIMPLE)	10.36%	0.00%	3.33%	-70.18%	-69.39%	0.00%	-73.60%	0.36%	1.29%	0.00%
Net Operating Profit after Tax (NOPAT)	18	133	0.70	-1,187	209	16	84	133	132	156
NOPAT Margin	1.86%	12.28%	0.09%	-118.36%	22.44%	1.80%	9.64%	14.97%	14.76%	16.69%
Net Nonoperating Expense Percent (NNEP)	0.58%	4.19%	2.24%	29.86%	4.19%	2.15%	1.73%	2.68%	1.77%	1.71%
Return On Investment Capital (ROIC_SIMPLE)	-	1.42%	-	-	-	0.22%	-	-	-	2.28%
Cost of Revenue to Revenue	59.12%	55.34%	57.81%	53.14%	54.29%	53.98%	52.19%	52.76%	51.79%	52.73%
SG&A Expenses to Revenue	13.21%	15.56%	21.91%	17.15%	17.92%	18.14%	19.59%	18.15%	18.64%	18.82%
R&D to Revenue	6.60%	6.72%	9.07%	7.48%	7.62%	7.84%	8.06%	7.44%	7.81%	6.95%
Operating Expenses to Revenue	28.51%	29.65%	42.07%	215.95%	33.05%	43.45%	35.60%	32.92%	33.93%	32.62%
Earnings before Interest and Taxes (EBIT)	119	148	3.00	-1,707	111	12	109	134	123	134
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	268	267	118	-1,599	212	118	205	229	217	227
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	1.09	1.23	1.31	2.87	2.32	2.76	3.66	3.93	3.05	3.02
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	1.41	1.56	1.62	1.86	1.50	1.88	2.40	2.45	2.06	1.95
Price to Earnings (P/E)	10.54	16.60	39.48	0.00	0.00	0.00	0.00	1,096.82	235.96	36.90
Dividend Yield	1.35%	1.06%	1.00%	0.82%	1.03%	0.86%	0.66%	0.67%	0.81%	0.84%
Earnings Yield	9.49%	6.02%	2.53%	0.00%	0.00%	0.00%	0.00%	0.09%	0.42%	2.71%
Enterprise Value to Invested Capital (EV/IC)	1.05	1.12	1.16	1.70	1.50	1.68	2.02	2.04	1.77	1.76
Enterprise Value to Revenue (EV/Rev)	2.68	2.69	2.75	2.95	2.56	2.96	3.46	3.58	3.18	3.02
Enterprise Value to EBITDA (EV/EBITDA)	9.85	10.26	11.73	0.00	0.00	0.00	0.00	16.76	14.64	12.34
Enterprise Value to EBIT (EV/EBIT)	13.41	15.75	22.89	0.00	0.00	0.00	0.00	34.99	29.79	21.67
Enterprise Value to NOPAT (EV/NOPAT)	17.24	20.11	27.41	0.00	0.00	0.00	0.00	48.91	19.87	20.61
Enterprise Value to Operating Cash Flow (EV/OCF)	15.99	18.04	18.83	31.31	30.29	33.64	36.61	24.16	21.13	20.52
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	12.63	10.46	11.01	19.95	15.82	14.15
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	1.20	1.10	1.11	1.97	1.97	1.94	1.96	2.19	2.01	1.95
Long-Term Debt to Equity	1.18	1.08	1.09	1.93	1.93	1.90	1.94	2.16	1.98	1.93
Financial Leverage	0.58	0.51	0.51	0.69	1.23	1.14	1.15	1.73	1.63	1.61
Leverage Ratio	2.28	2.18	2.14	2.49	3.10	2.96	2.95	3.83	3.73	3.69
Compound Leverage Factor	0.77	0.97	-56.40	2.61	0.61	-19.76	0.51	0.63	1.82	2.18
Debt to Total Capital	54.59%	52.36%	52.53%	66.29%	66.31%	65.96%	66.17%	68.62%	66.72%	66.15%
Short-Term Debt to Total Capital	1.04%	0.99%	0.94%	1.19%	1.18%	1.28%	0.70%	0.70%	0.69%	0.73%
Long-Term Debt to Total Capital	53.55%	51.37%	51.59%	65.10%	65.13%	64.67%	65.48%	67.91%	66.03%	65.42%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	45.41%	47.64%	47.47%	33.71%	33.69%	34.04%	33.83%	31.38%	33.28%	33.85%
Debt to EBITDA	5.69	5.30	5.84	-5.19	-4.86	-4.16	-4.46	6.39	6.25	5.17
Net Debt to EBITDA	4.68	4.32	4.80	-4.39	-4.01	-3.40	-3.66	5.28	5.13	4.36
Long-Term Debt to EBITDA	5.58	5.20	5.74	-5.09	-4.78	-4.08	-4.41	6.32	6.19	5.11
Debt to NOPAT	9.96	10.38	13.65	-4.96	-4.92	-4.40	-4.68	18.65	8.48	8.63
Net Debt to NOPAT	8.19	8.47	11.21	-4.19	-4.06	-3.60	-3.84	15.40	6.96	7.27
Long-Term Debt to NOPAT	9.77	10.19	13.41	-4.87	-4.84	-4.32	-4.63	18.46	8.39	8.54
Altman Z-Score	1.16	1.29	1.30	0.75	1.30	1.32	1.59	1.57	1.42	1.46
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.76	2.93	3.14	3.27	3.31	3.18	3.69	3.58	3.42	3.19
Quick Ratio	1.60	1.71	1.66	1.66	1.76	1.74	1.97	1.96	1.88	1.71
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-5,573	-5,705	-5,702	-4,954	1,971	2,130	2,259	513	277	396
Operating Cash Flow to CapEx	765.38%	347.17%	217.65%	-347.06%	1,000.00%	532.35%	372.22%	469.23%	740.91%	345.10%
Free Cash Flow to Firm to Interest Expense	-69.66	-67.91	-67.09	-56.30	21.20	21.74	23.53	4.38	4.02	6.71
Operating Cash Flow to Interest Expense	2.49	2.19	0.44	-0.67	1.72	1.85	0.70	1.04	2.36	2.98
Operating Cash Flow Less CapEx to Interest Expense	2.16	1.56	0.24	-0.86	1.55	1.50	0.51	0.82	2.04	2.12
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.41	0.44	0.45	0.55	0.37	0.35	0.36	0.40	0.39	0.41
Accounts Receivable Turnover	5.50	6.10	6.84	6.90	5.66	5.48	6.44	5.83	5.78	5.89
Inventory Turnover	2.39	2.57	2.42	2.50	2.13	2.01	1.95	1.93	1.92	1.99
Fixed Asset Turnover	6.64	6.30	6.40	6.65	5.39	4.57	4.74	4.66	4.63	4.61
Accounts Payable Turnover	6.45	6.73	7.53	8.72	5.84	5.26	5.96	6.31	6.07	5.62
Days Sales Outstanding (DSO)	66.40	59.84	53.35	52.89	64.48	66.66	56.69	62.60	63.19	61.99
Days Inventory Outstanding (DIO)	152.56	141.80	150.73	145.95	171.28	181.39	187.58	188.71	190.52	183.08
Days Payable Outstanding (DPO)	56.61	54.20	48.49	41.88	62.51	69.41	61.20	57.84	60.12	64.91
Cash Conversion Cycle (CCC)	162.36	147.44	155.58	156.96	173.25	178.65	183.07	193.48	193.58	180.16
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	8,252	8,500	8,495	6,644	6,490	6,386	6,320	6,264	6,345	6,146
Invested Capital Turnover	0.59	0.64	0.64	0.81	0.52	0.49	0.50	0.55	0.55	0.57
Increase / (Decrease) in Invested Capital	5,591	5,838	5,703	3,767	-1,762	-2,114	-2,175	-380	-145	-240
Enterprise Value (EV)	8,636	9,545	9,887	11,304	9,753	10,730	12,776	12,806	11,262	10,834
Market Capitalization	4,533	5,528	5,843	7,155	5,739	6,816	8,880	8,775	7,315	7,010
Book Value per Share	$74.43	$67.41	$66.76	$37.37	$37.03	$36.96	$36.18	$33.23	$35.64	$34.50
Tangible Book Value per Share	($60.19)	($45.08)	($44.76)	($42.06)	($40.05)	($40.39)	($38.63)	($39.88)	($38.82)	($36.09)
Total Capital	9,137	9,410	9,376	7,402	7,350	7,261	7,166	7,115	7,206	6,860
Total Debt	4,988	4,927	4,925	4,907	4,874	4,789	4,742	4,882	4,808	4,538
Total Long-Term Debt	4,893	4,834	4,837	4,819	4,787	4,696	4,692	4,832	4,758	4,488
Net Debt	4,103	4,017	4,044	4,149	4,014	3,914	3,896	4,031	3,947	3,824
Capital Expenditures (CapEx)	26	53	17	17	16	34	18	26	22	51
Debt-free, Cash-free Net Working Capital (DFCFNWC)	990	1,025	1,079	1,223	1,164	1,066	1,144	1,107	1,076	1,035
Debt-free Net Working Capital (DFNWC)	1,875	1,935	1,960	1,981	2,024	1,941	1,990	1,958	1,937	1,749
Net Working Capital (NWC)	1,780	1,842	1,872	1,893	1,937	1,848	1,940	1,908	1,887	1,699
Net Nonoperating Expense (NNE)	12	79	43	582	170	85	69	110	70	66
Net Nonoperating Obligations (NNO)	4,103	4,017	4,044	4,149	4,014	3,914	3,896	4,031	3,947	3,824
Total Depreciation and Amortization (D&A)	149	119	115	108	101	106	96	95	94	93
Debt-free, Cash-free Net Working Capital to Revenue	30.70%	28.90%	29.98%	31.87%	30.51%	29.43%	30.95%	30.92%	30.36%	28.86%
Debt-free Net Working Capital to Revenue	58.14%	54.55%	54.46%	51.63%	53.05%	53.59%	53.84%	54.69%	54.66%	48.77%
Net Working Capital to Revenue	55.19%	51.93%	52.01%	49.34%	50.77%	51.02%	52.49%	53.30%	53.24%	47.38%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.09	$0.57	($0.64)	($26.47)	$0.59	($1.02)	$0.22	$0.34	$0.92	$1.34
Adjusted Weighted Average Basic Shares Outstanding	61M	59.70M	66.70M	66.80M	66.90M	66.80M	67M	67.30M	67.40M	67.30M
Adjusted Diluted Earnings per Share	$0.09	$0.58	($0.64)	($26.47)	$0.58	($1.01)	$0.22	$0.33	$0.92	$1.34
Adjusted Weighted Average Diluted Shares Outstanding	61.10M	59.90M	66.70M	66.80M	67.10M	66.80M	67.40M	67.50M	67.60M	67.60M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	66.51M	66.67M	66.77M	66.86M	66.88M	67.06M	67.20M	67.29M	67.30M	67.38M
Normalized Net Operating Profit after Tax (NOPAT)	108	142	5.60	103	84	75	87	92	92	98
Normalized NOPAT Margin	11.30%	13.11%	0.71%	10.26%	9.01%	8.39%	10.00%	10.34%	10.31%	10.48%
Pre Tax Income Margin	4.19%	6.08%	-9.95%	-178.56%	2.36%	-8.96%	2.19%	2.48%	6.70%	8.45%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	1.49	1.76	0.04	-19.40	1.19	0.12	1.14	1.15	1.78	2.27
NOPAT to Interest Expense	0.22	1.59	0.01	-13.49	2.25	0.16	0.87	1.13	1.92	2.65
EBIT Less CapEx to Interest Expense	1.16	1.13	-0.16	-19.59	1.02	-0.22	0.95	0.92	1.46	1.41
NOPAT Less CapEx to Interest Expense	-0.10	0.96	-0.19	-13.68	2.08	-0.18	0.68	0.91	1.60	1.78
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	11.16%	15.62%	37.16%	-3.26%	-3.43%	-3.20%	-3.31%	750.00%	190.32%	31.05%
Augmented Payout Ratio	11.16%	15.62%	37.16%	-3.26%	-3.43%	-3.20%	-3.31%	750.00%	190.32%	31.05%

Frequently Asked Questions About MKS Instruments' Financials

When does MKS Instruments's fiscal year end?

According to the most recent income statement we have on file, MKS Instruments' financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has MKS Instruments' net income changed over the last 9 years?

MKS Instruments' net income appears to be on a downward trend, with a most recent value of $190 million in 2024, rising from $122.30 million in 2015. The previous period was -$1.84 billion in 2023. See MKS Instruments' forecast for analyst expectations on what’s next for the company.

What is MKS Instruments's operating income?

MKS Instruments's total operating income in 2024 was $498 million, based on the following breakdown:

Total Gross Profit: $1.71 billion
Total Operating Expenses: $1.21 billion

How has MKS Instruments revenue changed over the last 9 years?

Over the last 9 years, MKS Instruments' total revenue changed from $813.52 million in 2015 to $3.59 billion in 2024, a change of 340.8%.

How much debt does MKS Instruments have?

MKS Instruments' total liabilities were at $6.27 billion at the end of 2024, a 5.7% decrease from 2023, and a 5,473.2% increase since 2015.

How much cash does MKS Instruments have?

In the past 9 years, MKS Instruments' cash and equivalents has ranged from $227.57 million in 2015 to $966 million in 2021, and is currently $714 million as of their latest financial filing in 2024.

How has MKS Instruments' book value per share changed over the last 9 years?

Over the last 9 years, MKS Instruments' book value per share changed from 21.80 in 2015 to 34.50 in 2024, a change of 58.3%.

Related Companies

This page (NASDAQ:MKSI) was last updated on 5/5/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

MKS Instruments (MKSI) Financials

Frequently Asked Questions About MKS Instruments' Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

MKS Instruments (MKSI) Financials

Annual Income Statements for MKS Instruments

Quarterly Income Statements for MKS Instruments

Annual Cash Flow Statements for MKS Instruments

Quarterly Cash Flow Statements for MKS Instruments

Annual Balance Sheets for MKS Instruments

Quarterly Balance Sheets for MKS Instruments

Annual Metrics and Ratios for MKS Instruments

Quarterly Metrics and Ratios for MKS Instruments

Frequently Asked Questions About MKS Instruments' Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools